Top Markets
Coin of the day
Hcmed Hcmed

Hcmed

6934
Rangering i aksjer #20836
HCmed Innovations Co Ltd. specializes in creating advanced solutions for... HCmed Innovations Co Ltd. specializes in creating advanced solutions for respiratory treatment through the application of mesh technology. Their product line features devices such as Pulmogine and AdheResp. Beyond its core offerings, the company delivers extensive analytical services focused on aerosol characterization, helping clients optimize and develop new inhaled therapeutic products. This analytical assistance is provided in strict adherence to Pharmacopoeia standards. Founded on October 6, 2014, by Jason Cheng, Leon Tsai, Shaogi Huang, and Simon Hsieh, HCmed maintains its principal office in Taipei, Taiwan.
Aksjekurs
$3.83
Sist synkronisert: 2026-02-24
Markedsverdi
$120.91M
Endring (1 dag)
2.55%
Endring (1 år)
80.49%
Land
TW
Handel Hcmed (6934)

Kategori

P/B-forhold for Hcmed (6934)
P/B-forhold per 2026 TTM: 0
Ifølge Hcmed sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Hcmed fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH